Outset Medical, Inc.
OM
$15.04
-$1.02-6.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 115.27M | 113.69M | 114.73M | 116.43M | 125.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.27M | 113.69M | 114.73M | 116.43M | 125.08M |
| Cost of Revenue | 73.28M | 74.24M | 78.76M | 83.12M | 93.85M |
| Gross Profit | 41.99M | 39.45M | 35.97M | 33.30M | 31.22M |
| SG&A Expenses | 100.17M | 109.18M | 118.20M | 129.21M | 134.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 202.59M | 218.55M | 238.11M | 261.42M | 282.79M |
| Operating Income | -87.32M | -104.86M | -123.38M | -145.00M | -157.71M |
| Income Before Tax | -113.37M | -127.49M | -140.33M | -158.67M | -168.28M |
| Income Tax Expenses | 444.00K | 491.00K | 607.00K | 511.00K | 493.00K |
| Earnings from Continuing Operations | -113.82 | -127.98 | -140.94 | -159.18 | -168.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.82M | -127.98M | -140.94M | -159.18M | -168.77M |
| EBIT | -87.32M | -104.86M | -123.38M | -145.00M | -157.71M |
| EBITDA | -81.75M | -99.14M | -117.61M | -139.15M | -151.82M |
| EPS Basic | -29.22 | -37.32 | -41.55 | -47.13 | -50.67 |
| Normalized Basic EPS | -16.52 | -21.71 | -24.84 | -28.35 | -30.56 |
| EPS Diluted | -29.22 | -37.32 | -41.55 | -47.13 | -50.67 |
| Normalized Diluted EPS | -16.52 | -21.71 | -24.84 | -28.35 | -30.56 |
| Average Basic Shares Outstanding | 17.38M | 13.73M | 13.57M | 13.53M | 13.33M |
| Average Diluted Shares Outstanding | 17.38M | 13.73M | 13.57M | 13.53M | 13.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |